新冠肺炎疫苗接种对肉毒杆菌毒素治疗慢性偏头痛的影响：病例系列

IF 0.5 Q4 INFECTIOUS DISEASES

Archives of Clinical Infectious Diseases Pub Date : 2023-07-22 DOI:10.5812/archcid-135039

Delara Hazegh Fetratjoo, E. Jafari, M. Togha

{"title":"新冠肺炎疫苗接种对肉毒杆菌毒素治疗慢性偏头痛的影响：病例系列","authors":"Delara Hazegh Fetratjoo, E. Jafari, M. Togha","doi":"10.5812/archcid-135039","DOIUrl":null,"url":null,"abstract":"Introduction: Headache worsening has been previously reported following the coronavirus disease 2019 (COVID-19) vaccination. However, COVID vaccination's influence on managing chronic migraine (CM) with botulinum toxin is yet to be studied. Case Presentation: In this case series, we present five cases of CM, who had responded to abobotulinum toxin type A (BTX-A), but their number of headache days increased after COVID vaccination. Conclusions: In the case of vaccination with COVID vaccines, during the first month of administering botulinum toxin for the management of CM, there might be a decrease in the efficacy of botulinum toxin, which should be explained to the patients. The authors suggest that physicians postpone the administration of BTX-A for chronic migraine management to a later time at their discretion.","PeriodicalId":51793,"journal":{"name":"Archives of Clinical Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":0.5000,"publicationDate":"2023-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effect of COVID-19 Vaccination on Management of Chronic Migraine with Botulinum Toxin: A Case Series\",\"authors\":\"Delara Hazegh Fetratjoo, E. Jafari, M. Togha\",\"doi\":\"10.5812/archcid-135039\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Headache worsening has been previously reported following the coronavirus disease 2019 (COVID-19) vaccination. However, COVID vaccination's influence on managing chronic migraine (CM) with botulinum toxin is yet to be studied. Case Presentation: In this case series, we present five cases of CM, who had responded to abobotulinum toxin type A (BTX-A), but their number of headache days increased after COVID vaccination. Conclusions: In the case of vaccination with COVID vaccines, during the first month of administering botulinum toxin for the management of CM, there might be a decrease in the efficacy of botulinum toxin, which should be explained to the patients. The authors suggest that physicians postpone the administration of BTX-A for chronic migraine management to a later time at their discretion.\",\"PeriodicalId\":51793,\"journal\":{\"name\":\"Archives of Clinical Infectious Diseases\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.5000,\"publicationDate\":\"2023-07-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Archives of Clinical Infectious Diseases\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5812/archcid-135039\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Clinical Infectious Diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5812/archcid-135039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

摘要

简介：此前有报道称，2019冠状病毒病（新冠肺炎）疫苗接种后头痛恶化。然而，新冠疫苗接种对肉毒杆菌毒素治疗慢性偏头痛（CM）的影响尚待研究。病例介绍：在本病例系列中，我们介绍了5例CM病例，他们对A型肉毒杆菌毒素（BTX-A）有反应，但接种新冠疫苗后头痛天数增加。结论：在接种新冠疫苗的情况下，在使用肉毒杆菌毒素治疗CM的第一个月内，肉毒杆菌毒素的疗效可能会下降，这应该向患者解释。作者建议医生自行决定推迟服用BTX-A治疗慢性偏头痛。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Effect of COVID-19 Vaccination on Management of Chronic Migraine with Botulinum Toxin: A Case Series

Introduction: Headache worsening has been previously reported following the coronavirus disease 2019 (COVID-19) vaccination. However, COVID vaccination's influence on managing chronic migraine (CM) with botulinum toxin is yet to be studied. Case Presentation: In this case series, we present five cases of CM, who had responded to abobotulinum toxin type A (BTX-A), but their number of headache days increased after COVID vaccination. Conclusions: In the case of vaccination with COVID vaccines, during the first month of administering botulinum toxin for the management of CM, there might be a decrease in the efficacy of botulinum toxin, which should be explained to the patients. The authors suggest that physicians postpone the administration of BTX-A for chronic migraine management to a later time at their discretion.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Archives of Clinical Infectious Diseases INFECTIOUS DISEASES-

CiteScore

3.40

自引率

0.00%

发文量

期刊介绍： Archives of Clinical Infectious Diseases is a peer-reviewed multi-disciplinary medical publication, scheduled to appear quarterly serving as a means for scientific information exchange in the international medical forum. The journal particularly welcomes contributions relevant to the Middle-East region and publishes biomedical experiences and clinical investigations on prevalent infectious diseases in the region as well as analysis of factors that may modulate the incidence, course, and management of infectious diseases and pertinent medical problems in the Middle East.